ULTRAGENYX PHARMACEUTICAL INC earnings per share and revenue

UP0 earnings per share for the last quarter are -1.45 EUR whereas the estimation was -1.48 EUR which accounts for 1.74% surprise. Company revenue for the same period amounts to 128.75 M EUR despite the estimated figure of 132.94 M EUR. Estimated earnings per share for the next quarter are -1.10 EUR, and revenue is expected to reach 137.49 M EUR. Also watch annual changes over time to get a bigger picture of UP0 earnings per share and revenue dynamics.